Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: RxSight Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AEON Biopharma Inc. June 14, 20240.0%
-
RxSight Inc. June 6, 202475.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | AEON Biopharma Inc. | Grant or award | +222,684 | — | — |
| Jun 17, 2026 | RxSight Inc. | Grant or award | +37,037 | — | — |
| Jun 3, 2025 | RxSight Inc. | Grant or award | +10,752 | — | — |
| Aug 31, 2024 | AEON Biopharma Inc. | Grant or award | +36,021 | — | — |
| Jun 6, 2024 | RxSight Inc. | Grant or award | +2,554 | — | — |
| Jul 21, 2023 | AEON Biopharma Inc. | Derivative conversion | +6,900,000 | — | — |
| Jul 21, 2023 | AEON Biopharma Inc. | Derivative conversion | +89,163 | — | — |
| Jun 1, 2023 | RxSight Inc. | Grant or award | +5,731 | — | — |
Questions about Robert J. Palmisano
What boards is Robert J. Palmisano on?
Robert J. Palmisano sits on the boards of AEON Biopharma Inc. and RxSight Inc.
How long has Robert J. Palmisano served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.